Medical Radiation Shielding Market Size, Share, Growth Analysis, By Product (MRI Shielding Products, Lead-Lined Glass), By Material (Lead-based Shielding, Non-lead Shielding), By Solution (Radiation Therapy Shielding, Diagnostic Shielding), By End User, By Region - Industry Forecast 2024-2031

North America dominates the medical radiation shielding market, primarily due to its advanced healthcare infrastructure, widespread adoption of diagnostic imaging technologies, and the stringent regulatory standards. Strong North American focus on cancer therapies and use of radiation protection policies are also important factors contributing to its market leadership. According to the Society of Nuclear Medicine, the number of nuclear medicine procedures especially increased in the US, with nearly 20 million procedures performed annually to diagnose and treat the condition types, widely used in cardiology, cancer, neurology, and other medical fields.

Asia-Pacific is emerging as the dominant region in the medical radiation shielding market, with increasing demand for healthcare services, rising incidence of cancer, and expanding healthcare infrastructure. Countries such as China, India and Japan and a rapidly aging population are driving demand for advanced radiation protection solutions. Moreover, government initiatives to improve access to healthcare and safety standards are fueling market growth in Asia Pacific. The medical radiation shielding market in Asia Pacific is expected to grow at the fastest CAGR during the forecast period. This may be due to the increasing prevalence of chronic diseases, especially cancer, in the region.